Mutations in Capsid Major Homology Region Affect Assembly and Membrane Affinity of HIV-1 Gag

Journal of Molecular Biology

Volumn 370, Issue 3, 2007, Pages 585-597

  Chang, Yu Fen ^a,b   Wang, Shiu Mei ^a,b   Huang, Kuo Jung ^b   Wang, Chin Tien ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Gag membrane binding; Gag multimerization; HIV 1; major homology region (MHR); virus like particle assembly

Indexed keywords

GAG PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; DISEASE ASSOCIATION; GENE DELETION; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE BINDING; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN STRUCTURE; SEDIMENTATION; SEQUENCE HOMOLOGY; VIRUS CAPSID; VIRUS ENVELOPE; VIRUS LIKE AGENT; VIRUS MUTATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 34250155317     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.05.020     Document Type: Article

References (61)

1. Swanstrom R., and Wills J. Synthesis, assembly and processing of viral proteins. In: Coffin J., Hughes S., and Varmus H. (Eds). Retroviruses (1997), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 263-334
2. Freed E.O. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 251 (1998) 1-15
3. Delchambre M., G. D., Thines D., Thiriart C., Jacobs E., Verdin E., et al. The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J. 8 (1989) 2653-2660
4. Karacostas V., Nagashima K., Gonda M.A., and Moss B. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc. Natl Acad. Sci. USA 86 (1989) 8964-8967
5. Royer M., Hong S.S., Gay B., Cerutti M., and Boulanger P. Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus-infected cells. J. Virol. 66 (1992) 3230-3235
6. Gheysen D., Jacobs E., Foresta F.d., Thiriart C., Francotte M., Thines D., and Wilde M.D. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59 (1989) 103-112
7. Zhou W., Parent L.J., Wills J.W., and Resh M.D. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68 (1994) 2556-2569
8. Yuan X., Yu X., Lee T.H., and Essex M. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J. Virol. 67 (1993) 6387-6394
9. Ono A., and Freed E.O. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J. Virol. 73 (1999) 4136-4144
10. Spearman P., Wang J.J., Vander Heyden N., and Ratner L. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68 (1994) 3232-3242
11. Bryant M., and Ratner L. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl Acad. Sci. USA 87 (1990) 523-527
12. Tashiro A., Shoji S., and Kubota Y. Antimyristoylation of the gag proteins in the human immunodeficiency virus-infected cells with N-myristoyl glycinal diethylacetal resulted in inhibition of virus production. Biochem. Biophys. Res. Commun. 165 (1989) 1145-1154
13. Gottlinger H.G., Sodroski J.G., and Haseltine W.A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 86 (1989) 5781-5785
14. Rhee S.S., and Hunter E. Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J. Virol. 61 (1987) 1045-1053
15. Gottlinger H.G., Dorfman T., Sodroski J.G., and Haseltine W.A. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl Acad. Sci. USA 88 (1991) 3195-3199
16. Huang M., Orenstein J.M., Martin M.A., and Freed E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69 (1995) 6810-6818
17. Burniston M.T., Cimarelli A., Colgan J., Curtis S.P., and Luban J. Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein. J. Virol. 73 (1999) 8527-85240
18. Campbell S., and Vogt V.M. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J. Virol. 69 (1995) 6487-6497
19. Guo X., Roldan A., Hu J., Wainberg M.A., and Liang C. Mutation of the SP1 sequence impairs both multimerization and membrane-binding activities of human immunodeficiency virus type 1 Gag. J. Virol. 79 (2005) 1803-1812
20. Joshi A., Nagashima K., and Freed E.O. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, Gag-Gag interactions, Gag-membrane binding, and virion maturation. J. Virol. 80 (2006) 7939-7951
21. Liang C., Hu J., Russell R.S., Roldan A., Kleiman L., and Wainberg M.A. Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag. J. Virol. 76 (2002) 11729-11737
22. Melamed D., Mark-Danieli M., Kenan-Eichler M., Kraus O., Castiel A., Laham N., et al. The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release. J. Virol. 78 (2004) 9675-9688
23. Morikawa Y., Hockley D.J., Nermut M.V., and Jones I.M. Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly. J. Virol. 74 (2000) 16-23
24. von Schwedler U.K., Stray K.M., Garrus J.E., and Sundquist W.I. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 77 (2003) 5439-5450
25. Zhang Y., Qian H., Love Z., and Barklis E. Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain. J. Virol. 72 (1998) 1782-1789
26. Wills J.W., and Craven R.C. Form, function, and use of retroviral gag proteins. AIDS 5 (1991) 639-654
27. Renne R., Friedl E., Schweizer M., Fleps U., Turek R., and Neumann-Haefelin D. Genomic organization and expression of simian foamy virus type 3 (SFV-3). Virology 186 (1992) 597-608
28. Maurer B., Bannert H., Darai G., and Flugel R.M. Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J. Virol. 62 (1988) 1590-1597
29. Craven R.C., Leure-duPree A.E., Weldon Jr. R.A., and Wills J.W. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J. Virol. 69 (1995) 4213-4227
30. Srinivasakumar N., Hammarskjold M.L., and Rekosh D. Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J. Virol. 69 (1995) 6106-6114
31. Reicin A.S., Paik S., Berkowitz R.D., Luban J., Lowy I., and Goff S.P. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J. Virol. 69 (1995) 642-650
32. Strambio-de-Castillia C., and Hunter E. Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis. J. Virol. 66 (1992) 7021-7032
33. Mammano F., Ohagen A., Hoglund S., and Gottlinger H.G. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. 68 (1994) 4927-4936
34. Gamble T.R., Yoo S., Vajdos F.F., von Schwedler U.K., Worthylake D.K., Wang H., et al. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278 (1997) 849-853
35. Ivanov D., Stone J.R., Maki J.L., Collins T., and Wagner G. Mammalian SCAN domain dimer is a domain-swapped homolog of the HIV capsid C-terminal domain. Mol. Cell 17 (2005) 137-143
36. Sandefur S., Varthakavi V., and Spearman P. The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag. J. Virol. 72 (1998) 2723-2732
37. Ono A., Demirov D., and Freed E.O. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding. J. Virol. 74 (2000) 5142-5150
38. Chu H.H., Chang Y.F., and Wang C.T. Mutations in the alpha-helix directly C-terminal to the major homology region of human immunodeficiency virus type 1 capsid protein disrupt Gag multimerization and markedly impair virus particle production. J. Biomed. Sci. 13 (2006) 645-656
39. Tang S., Murakami T., Agresta B.E., Campbell S., Freed E.O., and Levin J.G. Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells. J. Virol. 75 (2001) 9357-9366
40. Paillart J.C., and Gottlinger H.G. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting. J. Virol. 73 (1999) 2604-2612
41. Spearman P., Horton R., Ratner L., and Kuli-Zade I. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J. Virol. 71 (1997) 6582-6592
42. Zhou W., and Resh M.D. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70 (1996) 8540-8548
43. Hermida-Matsumoto L., and Resh M.D. Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55gag and p17MA. J. Virol. 73 (1999) 1902-1908
44. Liang C., Hu J., Whitney J.B., Kleiman L., and Wainberg M.A. A structurally disordered region at the C terminus of capsid plays essential roles in multimerization and membrane binding of the Gag protein of human immunodeficiency virus type 1. J. Virol. 77 (2003) 1772-1783
45. Perez-Caballero D., Hatziioannou T., Martin-Serrano J., and Bieniasz P.D. Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions. J. Virol. 78 (2004) 9560-9563
46. Wang C.-T., Lai H.-Y., and Li J.-J. Analysis of minimal human immunodeficiency virus type 1 Gag coding sequences capable of virus-like particle assembly and release. J. Virol. 72 (1998) 7950-7959
47. Ono A., and Freed E.O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl Acad. Sci. USA 98 (2001) 13925-13930
48. Holm K., Weclewicz K., Hewson R., and Suomalainen M. Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100. J. Virol. 77 (2003) 4805-4817
49. Anderson R.G.W. The caveolae membrane system. Annu. Rev. Biochem. 67 (1998) 199-225
50. Lindwasser O.W., and Resh M.D. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J. Virol. 75 (2001) 7913-7924
51. Worthylake D.K., Wang H., Yoo S., Sundquist W.I., and Hill C.P. Structures of the HIV-1 capsid protein dimerization domain at 2.6 Å resolution. Acta Crystallog. sect. D 55 (1999) 85-92
52. Ivanov D., Tsodikov O.V., Kasanov J., Ellenberger T., Wagner G., and Collins T. Domain-swapped dimerization of the HIV-1 capsid C-terminal domain. Proc. Natl Acad. Sci. USA 104 (2007) 4353-4358
53. Ebbets-Reed D., Scarlata S., and Carter C.A. The major homology region of the HIV-1 gag precursor influences membrane affinity. Biochemistry 35 (1996) 14268-14275
54. Provitera P., Goff A., Harenberg A., Bouamr F., Carter C., and Scarlata S. Role of the major homology region in assembly of HIV-1 Gag. Biochemistry 40 (2001) 5565-5572
55. Tang C., Loeliger E., Luncsford P., Kinde I., Beckett D., and Summers M.F. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl Acad. Sci. USA 101 (2004) 517-522
56. Resh M.D. A myristoyl switch regulates membrane binding of HIV-1 Gag. Proc. Natl Acad. Sci. USA 101 (2004) 417-418
57. Chiu H.-C., Yao S.-Y., and Wang C.-T. Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160gag-pol into virus particles. J. Virol. 76 (2002) 3221-3231
58. Page K.A., Landau N.R., and Littman D.R. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64 (1990) 5270-5276
59. Wang C.T., and Barklis E. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J. Virol. 67 (1993) 4264-4273
60. Wang C.-T., Chou Y.-C., and Chiang C.-C. Assembly and processing of human immunodeficiency virus Gag mutants containing a partial replacement of the matrix domain by the viral protease domain. J. Virol. 74 (2000) 3418-3422
61. Fuerst T.R., Niles E.G., Studier F.W., and Moss B. Eukaryotic transient-expression system based on recombinant Vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl Acad. Sci. USA 83 (1986) 8122-8126